newsfilter
← Latest News
GlobeNewswire·

BillionToOne Announces Pricing of Upsized Initial Public Offering

MENLO PARK, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ:BLLN), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced